Nusrat Khan, Kaushik Chattopadhyay, Jo Leonardi-Bee
{"title":"南亚成人多重用药的发病率、流行率、危险因素和健康后果:一项系统审查方案。","authors":"Nusrat Khan, Kaushik Chattopadhyay, Jo Leonardi-Bee","doi":"10.11124/JBISRIR-D-18-00001","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The objective of the systematic review is to summarize the incidence, prevalence, risk factors and health consequences of polypharmacy in adults in South Asia.</p><p><strong>Introduction: </strong>Several studies have been conducted in South Asia on the incidence, prevalence, risk factors and health consequences of polypharmacy in adults. Until now, no systematic review has been conducted on this topic.</p><p><strong>Inclusion criteria: </strong>Related epidemiological studies conducted on adults (aged 18 years and over) and residing in any country within South Asia (i.e. Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan and Sri Lanka) will be eligible for inclusion.</p><p><strong>Methods: </strong>MEDLINE, Embase, CINAHL, PsycINFO, BNI, Web of Science, Scopus and AMED databases will be searched to identify published studies. The search for unpublished studies will be undertaken in EThOS, OpenGrey and ProQuest Dissertations and Theses. Databases will be searched from their inception dates and no language restrictions will be applied. The JBI systematic review methodology will be followed to conduct the review. Data synthesis will be conducted using narrative synthesis and meta-analyses, where appropriate.</p>","PeriodicalId":73539,"journal":{"name":"JBI database of systematic reviews and implementation reports","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.11124/JBISRIR-D-18-00001","citationCount":"4","resultStr":"{\"title\":\"Incidence, prevalence, risk factors and health consequences of polypharmacy in adults in South Asia: a systematic review protocol.\",\"authors\":\"Nusrat Khan, Kaushik Chattopadhyay, Jo Leonardi-Bee\",\"doi\":\"10.11124/JBISRIR-D-18-00001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>The objective of the systematic review is to summarize the incidence, prevalence, risk factors and health consequences of polypharmacy in adults in South Asia.</p><p><strong>Introduction: </strong>Several studies have been conducted in South Asia on the incidence, prevalence, risk factors and health consequences of polypharmacy in adults. Until now, no systematic review has been conducted on this topic.</p><p><strong>Inclusion criteria: </strong>Related epidemiological studies conducted on adults (aged 18 years and over) and residing in any country within South Asia (i.e. Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan and Sri Lanka) will be eligible for inclusion.</p><p><strong>Methods: </strong>MEDLINE, Embase, CINAHL, PsycINFO, BNI, Web of Science, Scopus and AMED databases will be searched to identify published studies. The search for unpublished studies will be undertaken in EThOS, OpenGrey and ProQuest Dissertations and Theses. Databases will be searched from their inception dates and no language restrictions will be applied. The JBI systematic review methodology will be followed to conduct the review. Data synthesis will be conducted using narrative synthesis and meta-analyses, where appropriate.</p>\",\"PeriodicalId\":73539,\"journal\":{\"name\":\"JBI database of systematic reviews and implementation reports\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.11124/JBISRIR-D-18-00001\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JBI database of systematic reviews and implementation reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.11124/JBISRIR-D-18-00001\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JBI database of systematic reviews and implementation reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11124/JBISRIR-D-18-00001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4
摘要
目的:本系统综述的目的是总结南亚成人多药的发病率、流行率、危险因素和健康后果。导言:在南亚开展了几项关于成人多药的发病率、流行率、危险因素和健康后果的研究。到目前为止，还没有关于这一主题的系统综述。纳入标准:对居住在南亚任何国家(即阿富汗、孟加拉国、不丹、印度、马尔代夫、尼泊尔、巴基斯坦和斯里兰卡)的成年人(18岁及以上)进行的相关流行病学研究将符合纳入标准。方法:检索MEDLINE、Embase、CINAHL、PsycINFO、BNI、Web of Science、Scopus和AMED数据库，确定已发表的研究。对未发表研究的搜索将在EThOS、OpenGrey和ProQuest的论文和论文中进行。数据库将从建立之日起进行检索，不受语言限制。将遵循JBI系统审查方法进行审查。数据综合将酌情采用叙述性综合和综合分析进行。
Incidence, prevalence, risk factors and health consequences of polypharmacy in adults in South Asia: a systematic review protocol.
Objective: The objective of the systematic review is to summarize the incidence, prevalence, risk factors and health consequences of polypharmacy in adults in South Asia.
Introduction: Several studies have been conducted in South Asia on the incidence, prevalence, risk factors and health consequences of polypharmacy in adults. Until now, no systematic review has been conducted on this topic.
Inclusion criteria: Related epidemiological studies conducted on adults (aged 18 years and over) and residing in any country within South Asia (i.e. Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan and Sri Lanka) will be eligible for inclusion.
Methods: MEDLINE, Embase, CINAHL, PsycINFO, BNI, Web of Science, Scopus and AMED databases will be searched to identify published studies. The search for unpublished studies will be undertaken in EThOS, OpenGrey and ProQuest Dissertations and Theses. Databases will be searched from their inception dates and no language restrictions will be applied. The JBI systematic review methodology will be followed to conduct the review. Data synthesis will be conducted using narrative synthesis and meta-analyses, where appropriate.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
